A computer method and software based on the in vitro dissolution ofdrug preparations has been elaborated for the estimation of bioequivalenceusing Microsoft Excel 2007, Visual Basic programming language. Themethod generates a „dissolution surface‖ from the parameters of time (Xaxis),from pH (Y-axis) and from the dissolved amount (A) in % of the drug.This dissolution surface allows the determination of the general dissolutioncurve of the test and reference preparations. By supposing that the absorptionrate constant is known from the literature, the change of the amount ofdissolved drug as the function of time can be determined. On the base of thisfunction the maximum amount of the dissolved drug in the gastrointestinaltract and the AUC can b...
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and ...
In vitro drug dissolution-time profiles can be used to predict in vivo drug plasma concentration-tim...
In order to assess and predict the bioequivalence (BE) of oral drug products, a new in vitro system ...
A computer method and software based on the in vitro dissolution ofdrug preparations has been elabor...
A computer method and software based on the in vitro dissolution ofdrug preparations has been elabor...
The Biopharmaceutics Classification System (BCS) is based on the mechanistic assumptions that the ra...
When dissolution testing is used to forecast the in vivoperformance of a drug, it is critical that t...
PubMed ID: 7867670Using in vitro dissolution and in vivo absorption of different generics or batches...
Department of Pharmaceutical and Toxicological Chemistry, Nicolae Testemitanu State University of M...
The use of computer programs to predict drug absorption in humans and to simulate dissolution profil...
The article analyzes comparatively the performance of the main methods proposed for the comparison o...
Background: Physiologically-based population pharmacokinetic modeling (popPBPK) coupled with in vitr...
In vitro dissolution has been recognized as an important element in drug development to assure the q...
Background Physiologically-based population pharmacokinetic modeling (popPBPK) coupled with in vitro...
<i>In silico</i> absorption modeling has been performed, to assess the impact of <i>in vitro</i> dis...
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and ...
In vitro drug dissolution-time profiles can be used to predict in vivo drug plasma concentration-tim...
In order to assess and predict the bioequivalence (BE) of oral drug products, a new in vitro system ...
A computer method and software based on the in vitro dissolution ofdrug preparations has been elabor...
A computer method and software based on the in vitro dissolution ofdrug preparations has been elabor...
The Biopharmaceutics Classification System (BCS) is based on the mechanistic assumptions that the ra...
When dissolution testing is used to forecast the in vivoperformance of a drug, it is critical that t...
PubMed ID: 7867670Using in vitro dissolution and in vivo absorption of different generics or batches...
Department of Pharmaceutical and Toxicological Chemistry, Nicolae Testemitanu State University of M...
The use of computer programs to predict drug absorption in humans and to simulate dissolution profil...
The article analyzes comparatively the performance of the main methods proposed for the comparison o...
Background: Physiologically-based population pharmacokinetic modeling (popPBPK) coupled with in vitr...
In vitro dissolution has been recognized as an important element in drug development to assure the q...
Background Physiologically-based population pharmacokinetic modeling (popPBPK) coupled with in vitro...
<i>In silico</i> absorption modeling has been performed, to assess the impact of <i>in vitro</i> dis...
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and ...
In vitro drug dissolution-time profiles can be used to predict in vivo drug plasma concentration-tim...
In order to assess and predict the bioequivalence (BE) of oral drug products, a new in vitro system ...